Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2009.01511.x ◽

2010 ◽

Vol 7 (1) ◽

pp. 59-69 ◽

Author(s):

Benedetta Fibbi ◽

Annamaria Morelli ◽

Linda Vignozzi ◽

Sandra Filippi ◽

Aravinda Chavalmane ◽

...

Keyword(s):

Urinary Tract ◽

Functional Activity ◽

Lower Urinary Tract ◽

Phosphodiesterase Type ◽

Download Full-text

Faculty Opinions recommendation of The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157814.7467056 ◽

2010 ◽

Author(s):

Apostolos Apostolidis

Keyword(s):

Erectile Dysfunction ◽

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

The Relationship ◽

Download Full-text

Genetic Characterization of 2 Novel Feline Caliciviruses Isolated from Cats with Idiopathic Lower Urinary Tract Disease

Journal of Veterinary Internal Medicine ◽

10.1111/j.1939-1676.2002.tb02372.x ◽

2002 ◽

Vol 16 (3) ◽

pp. 293-302 ◽

Author(s):

Cheryl C. Rice ◽

John M. Kruger ◽

Patrick J. Venta ◽

Aivars Vilnis ◽

Kara A. Maas ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Genetic Characterization ◽

Tract Disease ◽

Download Full-text

The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia ◽

10.1002/9781118437889.ch10 ◽

2014 ◽

pp. 113-128

Author(s):

Casey Lythgoe ◽

Kevin T. McVary

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis

World Journal of Urology ◽

10.1007/s00345-018-2370-z ◽

2018 ◽

Vol 37 (1) ◽

pp. 143-153 ◽

Author(s):

Jianzhong Zhang ◽

Xiao Li ◽

Bin Yang ◽

Cheng Wu ◽

Yanghua Fan ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Meta Analysis ◽

Prostatic Hyperplasia ◽

Alpha Blockers ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

Molecular characterization of extended spectrum beta-lactamases producing Enterobacteriaceae causing lower urinary tract infection in pediatric population

Journal of Infectious Diseases and Therapy ◽

10.4172/2332-0877-c1-033 ◽

2017 ◽

Vol 05 (06) ◽

Author(s):

Eltai N Omer

Keyword(s):

Urinary Tract Infection ◽

Urinary Tract ◽

Tract Infection ◽

Lower Urinary Tract ◽

Pediatric Population ◽

Lower Urinary Tract Infection ◽

Beta Lactamases ◽

Extended Spectrum Beta Lactamases ◽

Download Full-text

Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms

Korean Journal of Andrology ◽

10.5534/kja.2011.29.2.91 ◽

2011 ◽

Vol 29 (2) ◽

pp. 91 ◽

Author(s):

Sang Deuk Kim ◽

Jong Kwan Park

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

Characterization of the Beta-Adrenergic Receptors in the Lower Urinary Tract of the Cat

Scandinavian Journal of Urology and Nephrology ◽

10.3109/00365597709179954 ◽

1977 ◽

Vol 11 (3) ◽

pp. 211-217 ◽

Author(s):

Arne Nergårdh

Keyword(s):

Urinary Tract ◽

Adrenergic Receptors ◽

Lower Urinary Tract ◽

Beta Adrenergic Receptors ◽

Beta Adrenergic ◽

Download Full-text

Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/j.juro.2011.09.107 ◽

2012 ◽

Vol 187 (1) ◽

pp. 213-214

Author(s):

Steven A. Kaplan

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

1253 A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5-IS) FOR LOWER URINARY TRACT SYMPTOMS (LUTS) SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH)

The Journal of Urology ◽

10.1016/j.juro.2012.02.1571 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Mauro Gacci ◽

Giovanni Corona ◽

Matteo Salvi ◽

Linda Vignozzi ◽

Kevin T. McVary ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Meta Analysis ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

Phosphodiesterase Type 5 Inhibitors in the Management of Non-neurogenic Male Lower Urinary Tract Symptoms: Critical Analysis of Current Evidence

European Urology ◽

10.1016/j.eururo.2011.05.054 ◽

2011 ◽

Vol 60 (3) ◽

pp. 527-535 ◽

Author(s):

Juan I. Martínez-Salamanca ◽

Joaquin Carballido ◽

Ian Eardley ◽

Francois Giuliano ◽

Christian Gratzke ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Critical Analysis ◽

Lower Urinary Tract ◽

Current Evidence ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text